Physician profile
Preston E Harrison
NPI 1184652141
$21,025.80
in general payments reported to CMS, 2019-2025
64 companies · $3,413 in 2025
The $3,413 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,686 · 2020: $2,243 · 2021: $3,467 · 2022: $3,164 · 2023: $2,981 · 2024: $3,073 · 2025: $3,413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,155 · Education: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,154.69 |
| Education | $311.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $2,851.43 | 2019-2025 | Ingrezza, Ongentys |
| Novartis Pharmaceuticals Corporation | $1,812.18 | 2019-2025 | |
| Biogen, INC. | $1,696.89 | 2019-2025 | Tysabri, Vumerity, Skyclarys |
| Teva Pharmaceuticals USA, INC. | $1,488.89 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Emd Serono, INC. | $1,195.94 | 2019-2025 | Mavenclad |
| Abbvie INC. | $920.35 | 2021-2025 | |
| Sk Life Science, INC. | $741.55 | 2020-2025 | |
| Lundbeck LLC | $631.64 | 2019-2025 | Rexulti, Vyepti |
| Acadia Pharmaceuticals INC | $598.13 | 2019-2025 | Nuplazid |
| Ucb, INC. | $584.95 | 2019-2025 | Rystiggo |
| Genzyme Corporation | $563.71 | 2019-2022 | |
| Amgen INC. | $558.32 | 2019-2025 | Uplizna |
| Alexion Pharmaceuticals, INC. | $555.00 | 2019-2025 | Ultomiris |
| Livanova USA, INC. | $481.82 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Harmony Biosciences LLC | $419.77 | 2021-2025 | Wakix |
Show all 64 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preston Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.